Scinai Immunotherapeutics Ltd. (SCNI)
1.18
-0.03
(-2.48%)
USD |
NASDAQ |
Oct 09, 16:00
1.195
+0.02
(+1.27%)
After-Hours: 20:00
Scinai Immunotherapeutics Net Income (Quarterly) : -2.037M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.037M |
| March 31, 2026 | 3.567M |
| December 31, 2025 | -2.076M |
| September 30, 2025 | -2.120M |
| June 30, 2025 | -2.632M |
| March 31, 2025 | -1.549M |
| December 31, 2024 | -2.248M |
| September 30, 2024 | 10.49M |
| June 30, 2024 | -2.313M |
| March 31, 2024 | -2.183M |
| December 31, 2023 | -2.355M |
| September 30, 2023 | 3.096M |
| June 30, 2023 | -3.718M |
| March 31, 2023 | -3.482M |
| September 30, 2022 | 4.742M |
| June 30, 2022 | -3.843M |
| March 31, 2022 | -2.944M |
| December 31, 2021 | -3.409M |
| September 30, 2021 | -2.797M |
| June 30, 2021 | -3.674M |
| March 31, 2021 | -2.501M |
| December 31, 2020 | -4.230M |
| September 30, 2020 | 16.18M |
| June 30, 2020 | -11.95M |
| March 31, 2020 | -1.056M |
| Date | Value |
|---|---|
| December 31, 2019 | -9.522M |
| September 30, 2019 | -5.490M |
| June 30, 2019 | -13.18M |
| March 31, 2019 | 0.1554M |
| December 31, 2018 | -12.36M |
| September 30, 2018 | -0.6192M |
| June 30, 2018 | -7.125M |
| March 31, 2018 | -4.103M |
| December 31, 2017 | -3.534M |
| September 30, 2017 | 0.3661M |
| June 30, 2017 | -3.289M |
| March 31, 2017 | -3.217M |
| December 31, 2016 | -0.6344M |
| September 30, 2016 | -0.623M |
| June 30, 2016 | -0.6862M |
| March 31, 2016 | -0.4588M |
| December 31, 2015 | -0.8433M |
| September 30, 2015 | 0.0346M |
| June 30, 2015 | -1.357M |
| March 31, 2015 | -0.4703M |
| December 31, 2014 | -0.4596M |
| September 30, 2014 | -0.5061M |
| June 30, 2014 | -0.6436M |
| March 31, 2014 | -0.5621M |
| December 31, 2013 | -0.619M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Compugen Ltd. | -7.006M |
| Pluri, Inc. | -6.193M |
| Evogene Ltd. | -1.591M |
| CollPlant Biotechnologies Ltd. | -2.726M |
| Regentis Biomaterials Ltd. | -- |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.4679M |
| Total Expenses (Quarterly) | 2.505M |
| EPS Diluted (Quarterly) | -3.662 |
| Enterprise Value | 7.027M |
| Gross Profit Margin (Quarterly) | -272.2% |
| Profit Margin (Quarterly) | -435.4% |
| Earnings Yield | -37.50K% |
| Normalized Earnings Yield | -18452.97 |